Sign In

Gary S. Mezo

CEO, CMO, Founder of NanoBiotech Pharma, Inc. | R&D in Cardiology, Neurology & Urology

Gary S. Mezo is the CEO, Medical Director, and Founder of NanoBiotech Pharma, Inc., a company focused on innovative research and development in nanotechnology for medical applications. With nearly 30 years of experience in the pharmaceutical industry, he has been instrumental in advancing treatments related to nanobacteria, particularly through a product known as NanobacTX.

Mezo's professional background includes extensive expertise in clinical trials and various therapeutic areas such as cardiology and diabetes. His leadership at NanoBiotech Pharma emphasizes a commitment to developing effective solutions that address unmet medical needs. The company operates as a closely-held entity, having grown through bootstrapping methods, which highlights Mezo’s entrepreneurial spirit and dedication to innovation in healthcare.

He is based in the Greater Orlando area and maintains an active presence on LinkedIn, where he shares insights about his work and the advancements at NanoBiotech Pharma .123

Highlights

Jul 2 · linkedin

INFECTION & THE DEVELOPMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE - Time to Revisit this AHA - CIRCULATION Article about our NanobacTX

Apr 17 · linkedin

An Important New Book by author Douglas Mulhall has just been released April 10th on Amazon. Here's the link: https://a.co/d/7zeBOGx

#innovation #health #medicine #healthcare #socialnetworking #entrepreneurship #heart #vascular

Related Questions

What is NanobacTX and how does it work?
What are Gary Mezo's key achievements at NanoBiotech Pharma, Inc?
How did Gary Mezo start NanoBiotech Pharma, Inc?
What are the main research areas at NanoBiotech Pharma, Inc?
What makes Gary Mezo's leadership style unique?
Gary S. Mezo
Gary S. Mezo, photo 1
Gary S. Mezo, photo 2
Add to my network

Location

Greater Orlando